"Global Buprenorphine Market Overview:
Global Buprenorphine Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Buprenorphine Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Buprenorphine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Buprenorphine Market:
The Buprenorphine Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Buprenorphine Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Buprenorphine Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Buprenorphine market has been segmented into:
Analgesic
Opioid Antagonist
By Application, Buprenorphine market has been segmented into:
Injectables
Sublingual
Transdermal
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Buprenorphine market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Buprenorphine market.
Top Key Players Covered in Buprenorphine market are:
Mallinckrodt
Noramco
Unichem Laboratories Ltd.
Sanofi
Johnson Matthey
Arevipharma Gmbh
Resonance Laboratories Pvt. Ltd.
Sun Pharmaceutical Industries Limited
Rusan Pharma Ltd. Micro Orgo Chem
Faran Shimi Pharmaceutical
Indivior PLC
Titan Pharmaceuticals
Inc.
Hikma Pharmaceuticals PLC.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Buprenorphine Market by Type
4.1 Buprenorphine Market Snapshot and Growth Engine
4.2 Buprenorphine Market Overview
4.3 Analgesic
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Analgesic: Geographic Segmentation Analysis
4.4 Opioid Antagonist
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Opioid Antagonist: Geographic Segmentation Analysis
Chapter 5: Buprenorphine Market by Application
5.1 Buprenorphine Market Snapshot and Growth Engine
5.2 Buprenorphine Market Overview
5.3 Injectables
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Injectables: Geographic Segmentation Analysis
5.4 Sublingual
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Sublingual: Geographic Segmentation Analysis
5.5 Transdermal
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Transdermal: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Buprenorphine Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MALLINCKRODT
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 NORAMCO
6.4 UNICHEM LABORATORIES LTD.
6.5 SANOFI
6.6 JOHNSON MATTHEY
6.7 AREVIPHARMA GMBH
6.8 RESONANCE LABORATORIES PVT. LTD.
6.9 SUN PHARMACEUTICAL INDUSTRIES LIMITED
6.10 RUSAN PHARMA LTD. MICRO ORGO CHEM
6.11 FARAN SHIMI PHARMACEUTICAL
6.12 INDIVIOR PLC
6.13 TITAN PHARMACEUTICALS
6.14 INC.
6.15 HIKMA PHARMACEUTICALS PLC.
Chapter 7: Global Buprenorphine Market By Region
7.1 Overview
7.2. North America Buprenorphine Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Analgesic
7.2.4.2 Opioid Antagonist
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Injectables
7.2.5.2 Sublingual
7.2.5.3 Transdermal
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Buprenorphine Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Analgesic
7.3.4.2 Opioid Antagonist
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Injectables
7.3.5.2 Sublingual
7.3.5.3 Transdermal
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Buprenorphine Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Analgesic
7.4.4.2 Opioid Antagonist
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Injectables
7.4.5.2 Sublingual
7.4.5.3 Transdermal
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Buprenorphine Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Analgesic
7.5.4.2 Opioid Antagonist
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Injectables
7.5.5.2 Sublingual
7.5.5.3 Transdermal
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Buprenorphine Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Analgesic
7.6.4.2 Opioid Antagonist
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Injectables
7.6.5.2 Sublingual
7.6.5.3 Transdermal
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Buprenorphine Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Analgesic
7.7.4.2 Opioid Antagonist
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Injectables
7.7.5.2 Sublingual
7.7.5.3 Transdermal
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Buprenorphine Scope:
|
Report Data
|
Buprenorphine Market
|
|
Buprenorphine Market Size in 2025
|
USD XX million
|
|
Buprenorphine CAGR 2025 - 2032
|
XX%
|
|
Buprenorphine Base Year
|
2024
|
|
Buprenorphine Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Mallinckrodt, Noramco, Unichem Laboratories Ltd., Sanofi, Johnson Matthey, Arevipharma Gmbh, Resonance Laboratories Pvt. Ltd., Sun Pharmaceutical Industries Limited, Rusan Pharma Ltd. Micro Orgo Chem, Faran Shimi Pharmaceutical, Indivior PLC, Titan Pharmaceuticals, Inc., Hikma Pharmaceuticals PLC..
|
|
Key Segments
|
By Type
Analgesic
Opioid Antagonist
By Applications
Injectables
Sublingual
Transdermal
|
